We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Clinical Researcher for Enrolling Ineligible Subjects
FDA Warns Clinical Researcher for Enrolling Ineligible Subjects
August 9, 2017
The FDA issued a warning letter to a Texas clinical researcher, claiming he deviated from his own investigational plan by enrolling ineligible trial subjects.